Location: New York, NY
CIK: 0001766721 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 10, 2026
Total Value: $479M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. (BBIO) | 5,089,611 | $389M | 81.3% | $40.43 | +62.4% | COM | 10806X102 |
| SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 1,316,806 | $27.67M | 5.8% | $10.41 | +67.6% | COM | 87164F105 |
| GLUE | Monte Rosa Therapeutics Inc (GLUE) | 1,472,331 | $23.09M | 4.8% | $20.37 | -33.8% | COM | 61225M102 |
| BCAX | Bicara Therapeutics Inc. (BCAX) | 568,919 | $9.575M | 2.0% | $25.50 | -33.0% | COM | 055477103 |
| CMPS | Compass Pathways Plc (CMPS) | 1,198,418 | $8.269M | 1.7% | $6.51 | — | SPONSORED ADS | 20451W101 |
| BBOT | BridgeBio Oncology Therapeutics (BBOT) | 564,625 | $7.069M | 1.5% | $11.58 | — | COM NEW | 107924102 |
| CALC | CalciMedica, Inc. (CALC) | 521,114 | $3.434M | 0.7% | $4.55 | -14.2% | COM NEW | 38942Q202 |
| SRRK | Scholar Rock Holding Corporation (SRRK) | 77,031 | $3.393M | 0.7% | $34.98 | +7.2% | COM | 80706P103 |
| BMEA | Biomea Fusion Inc (BMEA) | 2,048,757 | $2.54M | 0.5% | $8.06 | -82.6% | COM | 09077A106 |
| URGN | Urogen Pharma Ltd. (URGN) | 108,000 | $2.529M | 0.5% | $21.69 | 0.0% | COM | M96088105 |
| ACRS | Aclaris Therapeutics Inc (ACRS) | 434,455 | $1.308M | 0.3% | $10.31 | -75.5% | COM | 00461U105 |
| MRKR | Marker Therapeutics, Inc. (MRKR) | 325,370 | $485K | 0.1% | $1.80 | -37.1% | COM NEW | 57055L206 |
| OKUR | OnKure Therapeutics, Inc. (OKUR) | 88,607 | $257K | 0.1% | $15.14 | -80.2% | COM CL A | 68277Q105 |